Aldeyra Therapeutics Inc - ESG Rating & Company Profile powered by AI
The webpage displays a free ESG report covering Aldeyra Therapeutics Inc. Full ESG analysis of Aldeyra Therapeutics Inc can be reached by registering for free. The ESG rating covers 17 United Nations SDGs including: 'Affordable & Clean Energy', 'Climate Action' and 'Life on Land'.
Aldeyra Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.9; made up of an environmental score of 4.0, social score of 1.6 and governance score of 3.2.
2.9
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1336 | SyneuRx International (Taiwan) Corp | 3.0 | Medium |
| 1336 | Sensorion SA | 3.0 | Medium |
| 1353 | Aldeyra Therapeutics Inc | 2.9 | Medium |
| 1353 | Caribou Biosciences Inc | 2.9 | Medium |
| 1353 | Checkmate Pharmaceuticals Inc | 2.9 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Aldeyra Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Aldeyra Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Aldeyra Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Aldeyra Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Aldeyra Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Aldeyra Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Aldeyra Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Aldeyra Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Aldeyra Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Aldeyra Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Aldeyra Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Aldeyra Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Aldeyra Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Aldeyra Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Aldeyra Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Aldeyra Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Aldeyra Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Aldeyra Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Aldeyra Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Aldeyra Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Aldeyra Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Aldeyra Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Aldeyra Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Aldeyra Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Aldeyra Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Aldeyra Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Aldeyra Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Aldeyra Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Aldeyra Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Aldeyra Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Aldeyra Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Aldeyra Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Aldeyra Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Aldeyra Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Aldeyra Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Aldeyra Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Aldeyra Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, an ophthalmic solution, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-2191, a dihydrofolate reductase inhibitor which is in phase 3 for the prevention of proliferative vitreoretinopathy, and phase II clinical trial for the treatment of primary vitreoretinal lymphoma. The company's portfolio also consists of ADX-1612, a small molecule heat shock protein 90 (Hsp90) inhibitor for the treatment of lymphoproliferative diseases and covid-19; and reactive aldehyde species that are pro-inflammatory (RASP) scavengers, such as ADX-629 for treating autoimmune diseases, allergy, and covid-19, as well as ADX-103 for the treatment of retinal diseases. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is headquartered in Lexington, Massachusetts.